Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

NIntellia Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
N

Intellia Therapeutics, Inc.

$12.69Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • History
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $7.66M. Net result −$106.63M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $7.66M. Running result $7.66M. Revenue: $7.66M.
  • Research and development: −$82.6M. Running result −$74.94M.
  • General and administrative: −$37.82M. Running result −$112.76M.
  • Operating income: −$112.76M. Running result −$112.76M.
  • Other income: $6.13M. Running result −$106.63M.
  • Pre-tax loss: −$106.63M. Running result −$106.63M.
  • Income tax benefit: $0. Running result −$106.63M.
  • Net loss: −$106.63M. Running result −$106.63M.